MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells

Susanne Husted, Rolf Søkilde, Lene Rask, Susanna Cirera, Peter Kamp Busk, Jens Eriksen, Thomas Litman

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftMol. Pharmaceutics
Vol/bind8
Udgave nummer6
Sider (fra-til)2055-2062
Antal sider8
DOI
StatusUdgivet - 1 dec. 2011
Udgivet eksterntJa

Citer dette

Husted, Susanne ; Søkilde, Rolf ; Rask, Lene ; Cirera, Susanna ; Busk, Peter Kamp ; Eriksen, Jens ; Litman, Thomas. / MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells. I: Mol. Pharmaceutics. 2011 ; Bind 8, Nr. 6. s. 2055-2062.
@article{430577e133164be1b8a0407881e6771a,
title = "MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells",
author = "Susanne Husted and Rolf S{\o}kilde and Lene Rask and Susanna Cirera and Busk, {Peter Kamp} and Jens Eriksen and Thomas Litman",
year = "2011",
month = "12",
day = "1",
doi = "10.1021/mp200255d",
language = "English",
volume = "8",
pages = "2055--2062",
journal = "Mol. Pharmaceutics",
publisher = "American Chemical Society (ACS)",
number = "6",

}

MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells. / Husted, Susanne; Søkilde, Rolf; Rask, Lene; Cirera, Susanna; Busk, Peter Kamp; Eriksen, Jens; Litman, Thomas.

I: Mol. Pharmaceutics, Bind 8, Nr. 6, 01.12.2011, s. 2055-2062.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells

AU - Husted, Susanne

AU - Søkilde, Rolf

AU - Rask, Lene

AU - Cirera, Susanna

AU - Busk, Peter Kamp

AU - Eriksen, Jens

AU - Litman, Thomas

PY - 2011/12/1

Y1 - 2011/12/1

U2 - 10.1021/mp200255d

DO - 10.1021/mp200255d

M3 - Journal article

VL - 8

SP - 2055

EP - 2062

JO - Mol. Pharmaceutics

JF - Mol. Pharmaceutics

IS - 6

ER -